Recruiting OBSERVATIONAL NCT06052397

Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium (SLEEP-POD)

Sponsor: Massachusetts General Hospital

Conditions Cognitive Decline Delirium, Postoperative Dementia

Updated 6 times since 2023 Last updated: Feb 9, 2026 Started: Sep 12, 2023 Primary completion: Sep 30, 2026 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06052397, this observational or N/A phase trial focuses on Cognitive Decline and Delirium, Postoperative and remains actively recruiting participants. Sponsored by Massachusetts General Hospital, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Dec 2024 — Feb 2026 [monthly]

Recruiting
Sep 2024 — Dec 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2023 — Nov 2023 [monthly]

Not Yet Recruiting

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States